Ethypharm Sells its Subsidiary in India
The pharmaceutical company Ethypharm recently announced it has sold all of its operations in India to Athena Pharm. Ethypharm leaves India in order to refocus its activities on Europe, the United States, China, and Japan; different markets where Ethypharm’s know-how and its competence in the development and registration sectors are renowned.
“The sale of our Indian subsidiary is part of the Ethypharm’s strategy to continue its growth by focusing our resources on our most profitable markets” said Hugues Lecat, Chairman and CEO of the Management Board of Ethypharm.
Present in
Ethypharm is one of the leading pharmaceutical companies dedicated to the development of innovative medicines. Its patented technologies offer multiple benefits for patients by improving efficacy, administration, compliance, and reducing side-effects. The company provides its clients with solutions for the life-cycle management of their drugs and has one of the broadest portfolios of technologies to become the worldwide privileged partner of pharmaceutical companies. Ethypharm offers customized solutions for the development of the medicines of the future.
Athena Pharm is the purchaser of the former subsidiary of Ethypharm in
Total Page Views: 2276
